SIMBA GILL, PH.D.
Simba is an entrepreneur, investor and CEO who believes passionately that science and globalization are the two forces that will dramatically improve life in the 21st century. He has founded and/or had lead roles in pioneering companies such as Systemix, Maxygen, Moksha8 and Evelo. He has also been an investor, advisor, founder and CEO of several emerging market life science companies and currently is a Senior Partner at Flagship Ventures.
Simba has an MBA from INSEAD and carried out his Ph.D. with focus on developing humanized antibodies to treat cancer. This work was done at King’s College, London in collaboration with the LMB at Cambridge and Celltech.